Arev

AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB

Retrieved on: 
Thursday, July 29, 2021
Arev, Dietary Supplements, Voynich, Information science, Databases

AREV, in collaboration with Voynich, will be pursuing definitive partnerships with government and non-governmental organizations to ensure the successful delivery of SUS-TAINN to the most seriously affected areas.

Key Points: 
  • AREV, in collaboration with Voynich, will be pursuing definitive partnerships with government and non-governmental organizations to ensure the successful delivery of SUS-TAINN to the most seriously affected areas.
  • This agreement between AREV and Voynich is intended as a first step in formalizing a long-term development collaboration.
  • We look forward to Dr. van Breemen joining Dr. Noller on the AREV Scientific Advisory Board (SAB), which would enormously enhance the Companys current capacities.
  • Dr. van Breemen, with a Ph.D. in Pharmacology and Experimental Therapeutics, co-founded the UIC/NIH Center for Botanical Dietary Supplements Research.

AREV Annual and Special General Meeting Results

Retrieved on: 
Tuesday, July 20, 2021
Arev

VANCOUVER, British Columbia, July 20, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV or the Company) is pleased to announce the outcome of the votes at the annual and special meetings of the shareholders of AREV Nanotec Brands Inc. held on July 13, 2021 in Vancouver, British Columbia.

Key Points: 
  • VANCOUVER, British Columbia, July 20, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV or the Company) is pleased to announce the outcome of the votes at the annual and special meetings of the shareholders of AREV Nanotec Brands Inc. held on July 13, 2021 in Vancouver, British Columbia.
  • In addition, on July 17, 2021, the AREV Board of Directors appointed U.S. entrepreneur Mr. Melvin S. Maxwell III as a new Director of the Company.
  • Mr. Mike Withrow, AREV CEO, stated, The Board of AREV welcomes the appointment of noted entrepreneur and investor Mel Maxwell as a new Director.
  • On July 13, 2021, AREV held its Annual and Special General Meeting; the results follow:
    The number of Directors was set to the election of six (6); this item was passed by ordinary resolution.

AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subsidiary, AREV Life Sciences, Inc.

Retrieved on: 
Tuesday, July 6, 2021
Genesee River, Rochester, New York, Arev, Rochester, Geography of New York state), Monroe County, New York, New York state)

AREVs formation of Rochester-based AREV Life Sciences Inc., a Delaware corporation (AREV Life Sciences), is a successful milestone in the growth strategy of AREV.

Key Points: 
  • AREVs formation of Rochester-based AREV Life Sciences Inc., a Delaware corporation (AREV Life Sciences), is a successful milestone in the growth strategy of AREV.
  • The subsidiarys placement in Rochester, New York has multiple advantages, including adjacency to the research facilities, programs, biotechnology enterprises, and human talent associated with the University of Rochester and New York State generally.
  • In addition, Denby Greenslade, an AREV director and its corporate secretary, will serve as the corporate secretary of the new subsidiary.
  • We look forward to the opportunity to access the talent and resources of the University of Rochester, Rochester Institute of Technology, and the established New York State infrastructure.

AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins For Use in Its Ready-To-Use Therapeutic Foods

Retrieved on: 
Wednesday, June 16, 2021
Articles, Countries, Land management, Soil, Cambodia, Rem, Arev, Nature

Mr. Rem Sareub, Head of Agriculture for AREV Cambodia has completed the soil and land survey of the companys 20 hectare leased land parcel in the Stoung District of Cambodia.

Key Points: 
  • Mr. Rem Sareub, Head of Agriculture for AREV Cambodia has completed the soil and land survey of the companys 20 hectare leased land parcel in the Stoung District of Cambodia.
  • The soil is grey sandy clay with worms and beneficial insects and has a pH of 7.
  • The following are the type of mushrooms grown by Mr. Rem, an expert in the agriculture field.
  • Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties.

AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock

Retrieved on: 
Friday, June 11, 2021
Arev, Warrant, Withrow

VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV or the Company) is pleased to announce that its Chief Executive Officer, Michael Withrow, has purchased a total of 900,000 shares, including private placement purchases and the exercising of warrants.

Key Points: 
  • VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV or the Company) is pleased to announce that its Chief Executive Officer, Michael Withrow, has purchased a total of 900,000 shares, including private placement purchases and the exercising of warrants.
  • Mr. Withrow commented: "When I study our core competencies and vision, along with the people working with the Company, I see a huge opportunity in the multiple markets that we operate in.
  • These relationships enable the Company to design and develop innovative products in a shorter time frame than current industry standards.
  • The company has issued 100,000 stock options to Directors, Officers and Consultants of the Company at a price of $0.185 for a period of 5 years from the issued date.

Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs

Retrieved on: 
Thursday, June 3, 2021
Demography, Arev, Disinfectant, Refugee camp, Refugee, Spray

The distribution partnership between Germinator and AREV will provide refugee and IDP populations with ongoing access to surface disinfectant treatments and air filtration systems to help curtail the transmission of contagious pathogens.

Key Points: 
  • The distribution partnership between Germinator and AREV will provide refugee and IDP populations with ongoing access to surface disinfectant treatments and air filtration systems to help curtail the transmission of contagious pathogens.
  • There are over 70 million people subject to significant overcrowding in more than 100 IDP and refugee camps around the world.
  • Throughout this partnership, AREV has been assigned distribution rights to Germinators platform of disinfecting products, including electrostatic sprayers and drone distribution that dispense Germinators disinfectant solution.
  • Surface remediation of COVID-19 is essential and creates a precedent for other confounding public health threats to vulnerable populations.

AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board

Retrieved on: 
Wednesday, June 2, 2021
Arev, Harold Smith

VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV) is pleased to announce the appointment of Dr. Harold C. Smith to its Scientific Advisory Board.

Key Points: 
  • VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV) is pleased to announce the appointment of Dr. Harold C. Smith to its Scientific Advisory Board.
  • Dr. Harold Smith is the founder, CEO, and president of OyaGen, Inc. (OyaGen), a biotechnology company developing therapeutics for infectious diseases and cancer.
  • Mike Withrow, CEO, stated, We are pleased to have Dr. Smith join our Scientific Advisory Board.
  • He will be a strong asset on the AREV SAB, stated Kevin Phelps, Board Chairman of OyaGen and a Director of AREV.

AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs

Retrieved on: 
Tuesday, June 1, 2021
Given names, Nobel laureates, Awards, Arev, American atheists, Linus Pauling, Pauling, Voynich, Oregon State University, Linus

The Company encourages its shareholders and interested parties to review the new website in light of this and recent news releases.

Key Points: 
  • The Company encourages its shareholders and interested parties to review the new website in light of this and recent news releases.
  • Mike Withrow, AREV CEO, said, AREV is becoming a fully integrated early-stage life sciences enterprise.
  • AREV is in a substantial growth stage through its advancement of creative collaborations with the advice of its high-level appointments to the Companys Scientific Advisory Board.
  • Through our SAB and our development of collaborations, with Voynich Biosciences, Inc. and Oyagen, AREV is connected to the Linus Pauling Institute at Oregon State University (OSU).

AREV Nanotec Board of Directors Welcomes Kevin Phelps

Retrieved on: 
Wednesday, February 24, 2021
Arev

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV Nanotec or AREV), is pleased to announce the addition of Kevin J. Phelps to its Board of Directors.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV Nanotec or AREV), is pleased to announce the addition of Kevin J. Phelps to its Board of Directors.
  • AREV Nanotec CEO Mike Withrow stated, I am excited to welcome Kevin Phelps to our Board of Directors.
  • Mr. Phelps is a graduate of the University of Notre Dame and a former Certified Public Accountant.
  • On behalf of the Board,
    About AREV NanoTec Brands Inc.
    AREV NanoTec Brands Inc. (CSE: AREV) (OTC: AREVF) produces phytomedicinal extracts via its proprietary state-of-the-art extraction methodologies for the life science industry.

AREV NanoTec joins BIO

Retrieved on: 
Tuesday, February 23, 2021
Arev, Global

VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV Nanotec or AREV), is pleased to announce that the Company has become a member of BIO, the Biotechnology Innovation Group, which is the worlds largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other countries.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV Nanotec or AREV), is pleased to announce that the Company has become a member of BIO, the Biotechnology Innovation Group, which is the worlds largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other countries.
  • AREV Nanotec CEO Mike Withrow stated, We are excited to join BIO at this critical point for both the Company and global public health.
  • BIO embodies some of the core values of AREV Nanotec, including commitment to discovery, global health and wellness, and good business practices in the life science industry.
  • On behalf of the Board,
    About AREV NanoTec Brands Inc.
    AREV NanoTec Brands Inc. (CSE: AREV) (OTC: AREVF) produces phytomedicinal extracts via its proprietary state-of-the-art extraction methodologies for the life science industry.